{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT01996436",
            "orgStudyIdInfo": {
                "id": "IVT_201310 (HSC-MS-13-0586)"
            },
            "organization": {
                "fullName": "The University of Texas Health Science Center, Houston",
                "class": "OTHER"
            },
            "briefTitle": "The Intra-arterial Vasospasm Trial",
            "officialTitle": "The Intra-arterial Vasospasm Trial(iVAST)- A Multi-center Randomized Study",
            "acronym": "iVAST",
            "therapeuticArea": [
                "Other"
            ],
            "study": "the-intra-arterial-vasospasm-trial"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-06",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2016-08-29",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2024-08",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2024-12",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2013-11-12",
            "studyFirstSubmitQcDate": "2013-11-21",
            "studyFirstPostDateStruct": {
                "date": "2013-11-27",
                "type": "ESTIMATED"
            },
            "lastUpdateSubmitDate": "2024-07-11",
            "lastUpdatePostDateStruct": {
                "date": "2024-07-12",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR_INVESTIGATOR",
                "investigatorFullName": "Peng Roc Chen, MD",
                "investigatorTitle": "Professor in Neurosurgery",
                "investigatorAffiliation": "The University of Texas Health Science Center, Houston"
            },
            "leadSponsor": {
                "name": "Peng Roc Chen, MD",
                "class": "OTHER"
            },
            "collaborators": [
                {
                    "name": "Yale University",
                    "class": "OTHER"
                },
                {
                    "name": "Thomas Jefferson University",
                    "class": "OTHER"
                },
                {
                    "name": "University of Illinois at Chicago",
                    "class": "OTHER"
                },
                {
                    "name": "Wake Forest University Health Sciences",
                    "class": "OTHER"
                },
                {
                    "name": "Temple University",
                    "class": "OTHER"
                },
                {
                    "name": "Geisinger Clinic",
                    "class": "OTHER"
                },
                {
                    "name": "Northwell Health",
                    "class": "OTHER"
                },
                {
                    "name": "University of Michigan",
                    "class": "OTHER"
                },
                {
                    "name": "Lenox Hill Hospital",
                    "class": "OTHER"
                },
                {
                    "name": "Weatherhead Foundation",
                    "class": "UNKNOWN"
                }
            ]
        },
        "oversightModule": {
            "oversightHasDmc": true
        },
        "descriptionModule": {
            "briefSummary": "The primary objective of the study is to determine the optimal intra-arterial drug treatment regimen for arterial lumen restoration post cerebral vasospasm following aneurysmal subarachnoid hemorrhage. The secondary objective is to evaluate clinical outcome at 90 days post discharge following optimal intra-arterial drug treatment for cerebral vasospasm.\n\nWe hypothesize that Intra-arterial (IA) infusion of a combination of multiple vasodilators is more efficacious than single agent treatment cerebral vasospasm therapy.\n\nAll procedures done as a part of this study are standard hospital care procedures done to treat cerebral vasospasm and all drugs to be used are FDA approved.",
            "detailedDescription": "The primary objective of the study is to determine the optimal intra-arterial drug treatment regimen for arterial lumen restoration post cerebral vasospasm following aneurysmal subarachnoid hemorrhage.\n\nThe secondary objective is to evaluate clinical outcome at 90 days post discharge following optimal intra-arterial drug treatment for cerebral vasospasm.\n\nThis study is a prospective multicenter randomized trial. The primary outcome measure is the Post infusion improvement ratio (PIIR) assessed 10 minutes after completion of the intra-arterial infusion. PIIR is a measure of arterial lumen diameter pre and post intra-arterial drug infusion in the presenting vasospasmic blood vessel.\n\nModified Rankin score (mRS) at 3 months post hospital discharge will be recorded as a secondary outcome to assess clinical outcome.\n\nThe interventions in this study are a part of routine standard of care (SOC) procedures for cerebral vasospasm treatment. Following surgical or endovascular intervention for aneurysmal Subarachnoid Hemorrhage (aSAH) if patients develop cerebral vasospasm refractory to maximal medical management, endovascular treatment by intra-arterial drug infusion of single drug agent or cocktail drug agents will be initiated.\n\nStudy participants will be randomly assigned to one of the three treatment groups where one single drug agent or cocktail drug agents will be intra-arterially administered. Pre \\& post infusion vasospasmic vessel diameters will be compared. The change in diameter will be quantified based on the mean percentage change. Three months post hospital discharge, study participants will be followed up in clinic to evaluate clinical outcome.\n\nThe study will require 330 patients in total. The patient population will be hospitalized patients presenting with cerebral vasospasm post aneurysmal subarachnoid hemorrhage.\n\nSubjects will be stratified by randomization into 3 treatment groups."
        },
        "conditionsModule": {
            "conditions": [
                "Cerebral Vasospasm"
            ],
            "keywords": [
                "cerebral vasospasm",
                "aneurysmal subarachnoid hemorrhage",
                "intra arterial drug treatment for cerebral vasospasm",
                "nicardipine milrinone nitroglycerin verapamil"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE4"
            ],
            "designInfo": {
                "allocation": "RANDOMIZED",
                "interventionModel": "PARALLEL",
                "primaryPurpose": "HEALTH_SERVICES_RESEARCH",
                "maskingInfo": {
                    "masking": "DOUBLE",
                    "whoMasked": [
                        "PARTICIPANT",
                        "OUTCOMES_ASSESSOR"
                    ]
                }
            },
            "enrollmentInfo": {
                "count": 330,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Nicardipine",
                    "type": "ACTIVE_COMPARATOR",
                    "description": "Group 1 : Nicardipine 5mg per circulation intra-arterial injection, Pharmacological angioplasty",
                    "interventionNames": [
                        "Drug: Nicardipine"
                    ]
                },
                {
                    "label": "Verapamil",
                    "type": "ACTIVE_COMPARATOR",
                    "description": "Group 3: Verapamil 10mg per circulation intra-arterial injection, Pharmacological angioplasty",
                    "interventionNames": [
                        "Drug: Verapamil"
                    ]
                },
                {
                    "label": "Nicardipine + Verapamil + Nitroglycerin",
                    "type": "ACTIVE_COMPARATOR",
                    "description": "Group 4 : Nicardipine 5mg + Verapamil 10mg + Nitroglycerin 200mcg in 4cc 5 % dextrose in water , intra-arterial injection, Pharmacological angioplasty",
                    "interventionNames": [
                        "Drug: Nicardipine + Verapamil + Nitroglycerin"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DRUG",
                    "name": "Nicardipine",
                    "description": "Pharmacological angioplasty: intra-arterial drug infusion via catheter to treat cerebral vasospasm",
                    "armGroupLabels": [
                        "Nicardipine"
                    ],
                    "otherNames": [
                        "Cardene"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Verapamil",
                    "description": "Pharmacological angioplasty: intra-arterial drug infusion via catheter to treat cerebral vasospasm",
                    "armGroupLabels": [
                        "Verapamil"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Nicardipine + Verapamil + Nitroglycerin",
                    "description": "Pharmacological angioplasty: intra-arterial drug infusion via catheter to treat cerebral vasospasm",
                    "armGroupLabels": [
                        "Nicardipine + Verapamil + Nitroglycerin"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Post infusion improvement ratio(PIIR)",
                    "description": "Post infusion improvement ratio(PIIR) = (B - A) / A\n\nA = pre-infusion blood vessel diameter B = post infusion blood vessel diameter\n\nPIIR across all four treatment arms will be compared and tested for statistical significance.",
                    "timeFrame": "pre pharmacological angioplasty blood vessel diameter - 0 min, post pharmacological angioplasty blood vessel diameter- 10 min after infusion"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "To grade clinical outcome using Modified Rankin score",
                    "description": "Clinical outcome at 3 months post discharge from hospital after treatment will be evaluated using Modified Rankin score",
                    "timeFrame": "3 months post discharge from hospital"
                }
            ],
            "otherOutcomes": [
                {
                    "measure": "Intra-cranial pressure",
                    "description": "Intra-cranial pressure will be measured 1 day prior to vasospasm treatment and 1 day after vasospasm treatment",
                    "timeFrame": "1 day prior to procedure & 1 day after the procedure"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* Adult patient, age 18-80 years old, with ruptured aneurysm(s) who experience cerebral vasospasm post operatively within 3-21 days.\n* Symptomatic vasospasm (clinical or TCD)\n* For centers that perform a routine day 7 angiogram post-aneurysm treatment - 50% or more stenosis seen on diagnostic angiogram for asymptomatic patients.\n\nExclusion Criteria:\n\n* Inability to obtain consent from patient or patients kin\n* Pregnant women\n* less than 18 years of age of more than 80 years of age\n* Hunt Hess Grade 5 SAH\n* Intra-arterial drug treatment in all 3 arterial territories",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "18 Years",
            "maximumAge": "80 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Peng R Chen, MD",
                    "role": "CONTACT",
                    "phone": "713-486-8016",
                    "email": "Peng.R.Chen@uth.tmc.edu"
                },
                {
                    "name": "Eddie Aguilar, BA",
                    "role": "CONTACT",
                    "phone": "713-486-7764",
                    "email": "Eddie.Aguilar@uth.tmc.edu"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Peng R Chen, MD",
                    "affiliation": "University of Texas Medical School at Houston",
                    "role": "PRINCIPAL_INVESTIGATOR"
                },
                {
                    "name": "Ketan R Bulsara, MD, MBA",
                    "affiliation": "UConn Health",
                    "role": "PRINCIPAL_INVESTIGATOR"
                }
            ],
            "locations": [
                {
                    "facility": "Yale School of Medicine",
                    "status": "TERMINATED",
                    "city": "New Haven",
                    "state": "Connecticut",
                    "zip": "06520",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 41.30815,
                        "lon": -72.92816
                    }
                },
                {
                    "facility": "University of Illinois College of Medicine at Chicago",
                    "status": "WITHDRAWN",
                    "city": "Chicago",
                    "state": "Illinois",
                    "zip": "60612",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 41.85003,
                        "lon": -87.65005
                    }
                },
                {
                    "facility": "University of Michigan",
                    "status": "WITHDRAWN",
                    "city": "Ann Arbor",
                    "state": "Michigan",
                    "zip": "48109",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 42.27756,
                        "lon": -83.74088
                    }
                },
                {
                    "facility": "Northwell Health",
                    "status": "RECRUITING",
                    "city": "Manhasset",
                    "state": "New York",
                    "zip": "11030",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "David Ledoux, MD",
                            "role": "CONTACT",
                            "phone": "516-562-3590"
                        },
                        {
                            "name": "Sarah Nazir",
                            "role": "CONTACT",
                            "email": "snazir1@northwell.edu"
                        }
                    ],
                    "geoPoint": {
                        "lat": 40.79788,
                        "lon": -73.69957
                    }
                },
                {
                    "facility": "Lenox Hill",
                    "status": "WITHDRAWN",
                    "city": "New York",
                    "state": "New York",
                    "zip": "10065",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 40.71427,
                        "lon": -74.00597
                    }
                },
                {
                    "facility": "Wake Forest University Health Sciences",
                    "status": "TERMINATED",
                    "city": "Winston-Salem",
                    "state": "North Carolina",
                    "zip": "27157",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 36.09986,
                        "lon": -80.24422
                    }
                },
                {
                    "facility": "Geisinger Clinic",
                    "status": "RECRUITING",
                    "city": "Danville",
                    "state": "Pennsylvania",
                    "zip": "17822",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Clemens Schirmer, MD",
                            "role": "CONTACT"
                        },
                        {
                            "name": "Chelsea Derr",
                            "role": "CONTACT",
                            "email": "cmderr1@geisinger.edu"
                        }
                    ],
                    "geoPoint": {
                        "lat": 40.96342,
                        "lon": -76.61273
                    }
                },
                {
                    "facility": "Thomas Jefferson University",
                    "status": "WITHDRAWN",
                    "city": "Philadelphia",
                    "state": "Pennsylvania",
                    "zip": "19107",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 39.95233,
                        "lon": -75.16379
                    }
                },
                {
                    "facility": "Temple University",
                    "status": "WITHDRAWN",
                    "city": "Philadelphia",
                    "state": "Pennsylvania",
                    "zip": "19140",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 39.95233,
                        "lon": -75.16379
                    }
                },
                {
                    "facility": "University of Texas Medical School at Houston",
                    "status": "RECRUITING",
                    "city": "Houston",
                    "state": "Texas",
                    "zip": "77030",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Sunil Sheth, MD",
                            "role": "CONTACT",
                            "email": "Sunil.A.Sheth@uth.tmc.edu"
                        },
                        {
                            "name": "Eddie Aguilar, BA",
                            "role": "CONTACT",
                            "phone": "713-486-7764",
                            "email": "Eddie.Aguilar@uth.tmc.edu"
                        },
                        {
                            "name": "Sunil Sheth, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 29.76328,
                        "lon": -95.36327
                    }
                }
            ]
        },
        "referencesModule": {
            "references": [
                {
                    "pmid": "18638721",
                    "type": "BACKGROUND",
                    "citation": "Dorsch NW, King MT. A review of cerebral vasospasm in aneurysmal subarachnoid haemorrhage Part I: Incidence and effects. J Clin Neurosci. 1994 Jan;1(1):19-26. doi: 10.1016/0967-5868(94)90005-1."
                },
                {
                    "pmid": "12744357",
                    "type": "BACKGROUND",
                    "citation": "Treggiari MM, Walder B, Suter PM, Romand JA. Systematic review of the prevention of delayed ischemic neurological deficits with hypertension, hypervolemia, and hemodilution therapy following subarachnoid hemorrhage. J Neurosurg. 2003 May;98(5):978-84. doi: 10.3171/jns.2003.98.5.0978. Erratum In: J Neurosurg. 2003 Dec;99(6):1119."
                },
                {
                    "pmid": "3176090",
                    "type": "BACKGROUND",
                    "citation": "Biller J, Godersky JC, Adams HP Jr. Management of aneurysmal subarachnoid hemorrhage. Stroke. 1988 Oct;19(10):1300-5. doi: 10.1161/01.str.19.10.1300. No abstract available."
                },
                {
                    "pmid": "3895589",
                    "type": "BACKGROUND",
                    "citation": "Kassell NF, Sasaki T, Colohan AR, Nazar G. Cerebral vasospasm following aneurysmal subarachnoid hemorrhage. Stroke. 1985 Jul-Aug;16(4):562-72. doi: 10.1161/01.str.16.4.562."
                },
                {
                    "pmid": "18312091",
                    "type": "BACKGROUND",
                    "citation": "Keuskamp J, Murali R, Chao KH. High-dose intraarterial verapamil in the treatment of cerebral vasospasm after aneurysmal subarachnoid hemorrhage. J Neurosurg. 2008 Mar;108(3):458-63. doi: 10.3171/JNS/2008/108/3/0458."
                },
                {
                    "pmid": "19057319",
                    "type": "BACKGROUND",
                    "citation": "Linfante I, Delgado-Mederos R, Andreone V, Gounis M, Hendricks L, Wakhloo AK. Angiographic and hemodynamic effect of high concentration of intra-arterial nicardipine in cerebral vasospasm. Neurosurgery. 2008 Dec;63(6):1080-6; discussion 1086-7. doi: 10.1227/01.NEU.0000327698.66596.35."
                },
                {
                    "pmid": "15140728",
                    "type": "BACKGROUND",
                    "citation": "Badjatia N, Topcuoglu MA, Pryor JC, Rabinov JD, Ogilvy CS, Carter BS, Rordorf GA. Preliminary experience with intra-arterial nicardipine as a treatment for cerebral vasospasm. AJNR Am J Neuroradiol. 2004 May;25(5):819-26."
                },
                {
                    "pmid": "20098322",
                    "type": "BACKGROUND",
                    "citation": "Pierot L, Aggour M, Moret J. Vasospasm after aneurysmal subarachnoid hemorrhage: recent advances in endovascular management. Curr Opin Crit Care. 2010 Apr;16(2):110-6. doi: 10.1097/MCC.0b013e3283372ef2."
                },
                {
                    "pmid": "18239182",
                    "type": "BACKGROUND",
                    "citation": "Fraticelli AT, Cholley BP, Losser MR, Saint Maurice JP, Payen D. Milrinone for the treatment of cerebral vasospasm after aneurysmal subarachnoid hemorrhage. Stroke. 2008 Mar;39(3):893-8. doi: 10.1161/STROKEAHA.107.492447. Epub 2008 Jan 31."
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "NO"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000020301",
                    "term": "Vasospasm, Intracranial"
                }
            ],
            "ancestors": [
                {
                    "id": "D000002561",
                    "term": "Cerebrovascular Disorders"
                },
                {
                    "id": "D000001927",
                    "term": "Brain Diseases"
                },
                {
                    "id": "D000002493",
                    "term": "Central Nervous System Diseases"
                },
                {
                    "id": "D000009422",
                    "term": "Nervous System Diseases"
                },
                {
                    "id": "D000014652",
                    "term": "Vascular Diseases"
                },
                {
                    "id": "D000002318",
                    "term": "Cardiovascular Diseases"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M9556",
                    "name": "Hemorrhage",
                    "relevance": "LOW"
                },
                {
                    "id": "M16135",
                    "name": "Subarachnoid Hemorrhage",
                    "relevance": "LOW"
                },
                {
                    "id": "M22114",
                    "name": "Vasospasm, Intracranial",
                    "asFound": "Cerebral Vasospasm",
                    "relevance": "HIGH"
                },
                {
                    "id": "M5810",
                    "name": "Cerebrovascular Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "M5204",
                    "name": "Brain Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M5742",
                    "name": "Central Nervous System Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M17400",
                    "name": "Vascular Diseases",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC23",
                    "name": "Symptoms and General Pathology"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "BC10",
                    "name": "Nervous System Diseases"
                },
                {
                    "abbrev": "BC14",
                    "name": "Heart and Blood Diseases"
                }
            ]
        },
        "interventionBrowseModule": {
            "meshes": [
                {
                    "id": "D000014700",
                    "term": "Verapamil"
                },
                {
                    "id": "D000009529",
                    "term": "Nicardipine"
                },
                {
                    "id": "D000005996",
                    "term": "Nitroglycerin"
                }
            ],
            "ancestors": [
                {
                    "id": "D000014665",
                    "term": "Vasodilator Agents"
                },
                {
                    "id": "D000000889",
                    "term": "Anti-Arrhythmia Agents"
                },
                {
                    "id": "D000002121",
                    "term": "Calcium Channel Blockers"
                },
                {
                    "id": "D000049990",
                    "term": "Membrane Transport Modulators"
                },
                {
                    "id": "D000045504",
                    "term": "Molecular Mechanisms of Pharmacological Action"
                },
                {
                    "id": "D000077264",
                    "term": "Calcium-Regulating Hormones and Agents"
                },
                {
                    "id": "D000045505",
                    "term": "Physiological Effects of Drugs"
                },
                {
                    "id": "D000000959",
                    "term": "Antihypertensive Agents"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M17446",
                    "name": "Verapamil",
                    "asFound": "Aromatase",
                    "relevance": "HIGH"
                },
                {
                    "id": "M12469",
                    "name": "Nicardipine",
                    "asFound": "Eculizumab",
                    "relevance": "HIGH"
                },
                {
                    "id": "M9102",
                    "name": "Nitroglycerin",
                    "asFound": "Nitric Oxide",
                    "relevance": "HIGH"
                },
                {
                    "id": "M21943",
                    "name": "Milrinone",
                    "relevance": "LOW"
                },
                {
                    "id": "M17412",
                    "name": "Vasodilator Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M4213",
                    "name": "Anti-Arrhythmia Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M5384",
                    "name": "Calcium Channel Blockers",
                    "relevance": "LOW"
                },
                {
                    "id": "M5381",
                    "name": "Calcium",
                    "relevance": "LOW"
                },
                {
                    "id": "M5398",
                    "name": "Calcium, Dietary",
                    "relevance": "LOW"
                },
                {
                    "id": "M9789",
                    "name": "Hormones",
                    "relevance": "LOW"
                },
                {
                    "id": "M4277",
                    "name": "Antihypertensive Agents",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "AnArAg",
                    "name": "Anti-Arrhythmia Agents"
                },
                {
                    "abbrev": "ChanBlk",
                    "name": "Channel Blockers"
                },
                {
                    "abbrev": "VaDiAg",
                    "name": "Vasodilator Agents"
                },
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                },
                {
                    "abbrev": "AnAg",
                    "name": "Antihypertensive Agents"
                },
                {
                    "abbrev": "CaAg",
                    "name": "Cardiotonic Agents"
                },
                {
                    "abbrev": "PlAggInh",
                    "name": "Platelet Aggregation Inhibitors"
                },
                {
                    "abbrev": "BDCA",
                    "name": "Bone Density Conservation Agents"
                }
            ]
        }
    },
    "hasResults": false
}